Eye drop trial offers hope for wet AMD patients
NCT ID NCT06704009
Summary
This early-stage study is testing whether NT-101 eye drops are safe and might help control wet age-related macular degeneration (AMD), a leading cause of vision loss in older adults. The trial will enroll 30 participants aged 50+ who have active wet AMD in one eye. Researchers will monitor side effects and look for early signs that the drops might reduce fluid buildup and help preserve vision.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WET AGE-RELATED MACULAR DEGENERATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Duke Eye Center
Durham, North Carolina, 27705, United States
-
Elman Retina Group
Rosedale, Maryland, 21237, United States
-
Erie Retina Research
Erie, Pennsylvania, 16505, United States
-
Texas Retina Associates
Dallas, Texas, 75231, United States
Conditions
Explore the condition pages connected to this study.